ScreenerHero
ABLDABL Diagnostics Société anonyme
EPA · FR · Healthcare · Health Information Services · abldiagnostics.com
2.340EUR+6.36%Mkt Cap: 40.90M $P/E: 39.00

ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and intern…

Industry Peers

Health Information Services
Screen all
VEE
Veeva System Inc. R
$38.07BUSDP/E 44.2
VEEV
Veeva Systems Inc Class A
$40.77BUSDP/E 44.6
BTSG
BrightSpring Health Services Inc. Common Stock
$11.74BUSDP/E 53.0
TEM
Tempus AI Inc. Class A Common Stock
$11.05BUSD
HQY
HealthEquity, Inc.
$8.71BUSDP/E 38.9
TXG
10x Genomics, Inc.
$8.10BUSD
HNGE
Hinge Health Inc. Class A Common Stock
$7.14BUSDP/E 10.8
WAY
Waystar Holding Corp. Common Stock
$4.76BUSDP/E 35.5
DOCS
Doximity, Inc.
$4.62BUSDP/E 30.9
HTFL
Heartflow Inc. Common Stock
$3.96BUSD
PRVA
Privia Health Group, Inc.
$2.75BUSDP/E 97.7
OMCL
Omnicell, Inc.
$1.66BUSDP/E 43.4
OMDA
Omada Health Inc. Common Stock
$1.50BUSDP/E 36.5
SDGR
Schrödinger, Inc.
$1.48BUSD
CERT
Certara, Inc.
$1.28BUSD
GDRX
GoodRx Holdings, Inc.
$1.21BUSDP/E 59.0
TDOC
Teladoc Health, Inc.
$1.18BUSD
TALK
Talkspace Inc. Common Stock
$870.57MUSD
HSTM
HealthStream, Inc.
$834.80MUSDP/E 39.7
PHR
Phreesia, Inc.
$738.82MUSDP/E 74.8

Key Statistics

Company
Market Cap40.90M $
Enterprise Value39.44M $
Revenue (TTM)8.66M $
Gross Profit7.20M $
Net Income (TTM)1.07M $
Revenue/Share0.5261 USD
Last Price2.340 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees22
CountryFR
SectorHealthcare
IndustryHealth Information Services
ISINFR001400AHX6
Valuation
P/E (Trailing)39.00
P/E (Forward)—
PEG1.94
EV/EBITDA84.71
EV/Revenue4.56
P/S4.44
P/B4.63
EPS (TTM)0.06
EPS (Forward)—
52W Range
2.1208% of range5.000
52W High5.000 EUR
52W Low2.120 EUR
Profitability
Gross Margin95.29%
Oper. Margin8.18%
EBITDA Margin5.38%
Profit Margin14.20%
ROE12.93%
ROA7.62%
Growth
Revenue Growth58.80%
Earnings Growth300.70%
Cash Flow & Leverage
Operating CF1.64M $
CapEx (TTM)861.60K $
FCF Margin13.27%
FCF Yield2.81%
Net Debt1.01M $
Net Debt/EBITDA2.18
Balance Sheet
Debt/Equity0.29
Current Ratio2.41
Quick Ratio2.08
Book Value/Sh0.4750 EUR
Cash/Share0.0820 EUR
Dividends
Fwd Div Rate0.1100 EUR
Trail. Div Rate0.1100 EUR
Div. Yield4.66%
5Y Avg Yield—
Payout Ratio81.43%
Ex-Div DateJul 3, 2026
Pay Date—
Splits
Last Split8:1
Split DateMay 18, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.16.08M
Float983.93K
Insiders93.57%
Institutions0.00%
Technical
SMA 502.497 (-6.3%)
SMA 2003.003 (-22.1%)
Beta-0.56
S&P 52W Chg18.16%
Avg Vol (30d)7.02K
Avg Vol (10d)4.96K
Technical Indicators
RSI (14)35.4
MACD-0.0457
MACD Signal-0.0299
MACD Hist.-0.0157
BB Upper2.611 EUR
BB Middle2.449 EUR
BB Lower2.287 EUR
BB Width13.22%
ATR (14)0.1466 EUR
Vol Ratio (20d)3.23x